Picture of Catalyst Pharmaceuticals logo

CPRX Catalyst Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Catalyst Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line31.97539.583.171.4
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items3.787.046.3613.194.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.1-4.115.0213.7-37.3
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities34.64560.4116144
Capital Expenditures-0.019-0.011-1.02-0.029-0.231
Purchase of Fixed Assets
Other Investing Cash Flow Items37.2-5-109.24-293
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities37.2-5.01-119.21-294
Financing Cash Flow Items0-0.056-0.153-0.968-13.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities1.120.702-8.141.69-10.9
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7340.741.2127-161